Collaborations

Biopharmaceuticals company announces research collaboration with Biogen Idec

Published in Vaccine Weekly, June 22nd, 2005

Rincon Pharmaceuticals, Inc. announced a collaborative research project with Biogen Idec, Inc. (BIIB) to evaluate Rincon's eukaryotic algae production platform for therapeutic non-glycosylated proteins.

Rincon has demonstrated the utility of algae as a system for the expression and assembly of complex mammalian proteins, including monoclonal antibodies.

Rincon Pharmaceuticals is a San Diego, California-based biopharmaceuticals company using eukaryotic algae to produce human therapeutic proteins, especially monoclonal antibodies. Rincon intends to use its proprietary technology to develop and manufacture both partnered and proprietary protein-based...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2005-06-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry